Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€19.82
-€0.03(-0.16%)
At close: 4:00 PM EDT
€19.82
-€0.03(-0.16%)
Day’s Range― - ―
52-Week Range€17.04 - €25.20
Previous CloseN/A
Volume103.79K
Average Volume (3M)131.98K
Market Cap
€1.41B
Enterprise Value€1.66B
Total Cash (Recent Filing)€36.00M
Total Debt (Recent Filing)€517.60M
Price to Earnings (P/E)22.7
Beta0.97
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.61%
Share Statistics
EPS (TTM)1.08
Shares Outstanding58,250,310
10 Day Avg. Volume171,222
30 Day Avg. Volume131,977
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€20.50Price Target Upside3.43% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)1.32
Revenue Forecast (FY)€1.29B
Bulls Say, Bears Say
Bulls Say
Deleveraging And Balance-sheet ImprovementMaterial debt reduction has lowered balance-sheet risk and should improve financial flexibility over the next several quarters. A stronger equity base relative to debt can support investment, absorb operating volatility, and reduce the constraints that previously affected capital allocation.
Sustained Positive Cash GenerationConsistently positive operating cash flow and a return to positive free cash flow indicate improved cash discipline and underlying funding capacity. This supports debt reduction, ongoing investment, and shareholder distributions without relying as heavily on external financing.
Embedded B2B Customer RelationshipsApplication expertise helps embed Corbion’s ingredients and materials in customer formulations, creating practical switching costs and repeat purchasing. These relationships can strengthen retention and provide a durable commercial advantage across food and industrial value chains.
Bears Say
Multi-year Revenue SoftnessSeveral years of declining revenue indicate that the company is operating in a challenged growth environment rather than benefiting from consistent volume or pricing expansion. Persistent top-line softness can limit operating leverage, investment capacity, and confidence in future earnings growth.
Uneven Net Income ConversionThe large variation in bottom-line profitability makes earnings power less predictable and weakens confidence in the durability of reported margins. Uneven conversion from revenue to net income can complicate planning, reduce resilience during weaker periods, and constrain dependable capital returns.
Variable Free Cash Flow And Shrinking Asset BaseAlthough free cash flow remains positive, its 2025 decline and earlier swings show that cash generation is not fully consistent through the cycle. Combined with a smaller asset base, this may limit flexibility to fund expansion and makes future operating performance more important.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €17.04 and its highest was €25.20 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.41B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Feb 26, 2027 which is in 123 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Jul 31, 2026. The company reported €0.51 earnings per share for the quarter, beating the consensus estimate of €0.49 by €0.02.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Notavailable dividend of €1 which represents an annual dividend yield of 2.61%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.51 in its last earnings report, beating expectations of €0.49. Following the earnings report the stock price went down -2.923%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. It operates through the following segments: Food and Biochemicals. The Food segment provides biobased ingredients for the food industry. The Biochemicals segment produces chemicals derived from organic acids through the fermentation of carbohydrates, and lactic acid based solutions. The company was founded on August 21, 1919 and is headquartered in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€20.50
▲(3.43% Upside)